AccuPulse

Suzhou, China · Founded 2020 · Privately Held (backing)

Developer of a pulsed field ablation (PFA) system intended to treat Atrial fibrillation (A-fib). AccuPulse is based in Suzhou, China and was founded in 2020. It has raised $64.6 million.

Last price · $/share

—

Implied valuation

—

Total raised

$64.6M

Last round

—

How much has AccuPulse raised?

$64.6Macross 0 recorded rounds

Free account

More of AccuPulse with a free account

·Watch AccuPulse: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AccuPulse investors

10 investors are on record for AccuPulse, including CICC Capital, Qianhai FoF, YuanBio Venture Capital and Leader Venture Capital. By type, the record holds 2 venture capital firms, 2 private equity firms and 1 fund of funds.

For fundraisers

Raising for a company like AccuPulse?

10 investors have backed AccuPulse.

See all 10 investors →

Frequently asked about AccuPulse

How much has AccuPulse raised?: AccuPulse has raised $64.6M in total across 0 recorded funding rounds.